Suppr超能文献

分析前因素对循环微RNA分析的影响

The Influence of Pre-Analytical Factors on the Analysis of Circulating MicroRNA.

作者信息

Shiotsu Hiromichi, Okada Kazuhiro, Shibuta Tatsuki, Kobayashi Yuki, Shirahama Saki, Kuroki Chieri, Ueda Saori, Ohkuma Masanori, Ikeda Katsuyoshi, Ando Yukio, Matsui Hirotaka, Kayamori Yuzo, Umemura Tsukuru

机构信息

Department of Health Sciences, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Department of Laboratory Medicine, Kumamoto University Hospital, Kumamoto, Japan.

出版信息

Microrna. 2018;7(3):195-203. doi: 10.2174/2211536607666180709143335.

Abstract

BACKGROUND

MicroRNAs (miRNA) are expected as useful biomarkers for various diseases. We studied the pre-analytical factors causing variation in the analysis of miRNA.

MATERIAL AND METHODS

Blood samples were collected from 25 healthy subjects. Plasma and serum were obtained from the same samples. The levels of miR-451, -16, -126, and -223 were analyzed using RT-qPCR. Cel-miR-39 was added as a spiked-in control in each sample.

RESULTS

With the exception of miR-451, the levels of the miRNAs in plasma were higher than in serum. After high-speed centrifugation, the levels of miRNAs were almost equal between plasma and serum except for miR-451. Membrane filtration with 0.45 µm pore size reduced the levels of plasma miRNAs. The coagulation accelerators for serum processing did not affect the analysis of miRNA. The use of fraction containing particles of > 0.45 µm in size showed the inhibitory effect on the analysis of plasma miR-451. The RNase inhibitor was effective for protecting against the degradation of miRNAs.

CONCLUSION

Plasma contains factors modifying miRNA profiles. The immediate processing of plasma with membrane filtration and RNase inhibitor may be a relevant method for achieving the stable analysis of miRNA.

摘要

背景

微小RNA(miRNA)有望成为各种疾病的有用生物标志物。我们研究了导致miRNA分析变异的分析前因素。

材料与方法

从25名健康受试者采集血样。从相同样本中获得血浆和血清。使用RT-qPCR分析miR-451、-16、-126和-223的水平。在每个样本中加入Cel-miR-39作为加标对照。

结果

除miR-451外,血浆中miRNA的水平高于血清。高速离心后,除miR-451外,血浆和血清中miRNA的水平几乎相等。用孔径为0.45 µm的膜过滤可降低血浆miRNA的水平。用于血清处理的凝血促进剂不影响miRNA的分析。使用含有尺寸大于0.45 µm颗粒的级分对血浆miR-451的分析有抑制作用。RNase抑制剂对防止miRNA降解有效。

结论

血浆含有改变miRNA谱的因素。用膜过滤和RNase抑制剂对血浆进行即时处理可能是实现miRNA稳定分析的一种相关方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/837f/6225341/0fbe7c4ca0b4/MIRNA-7-195_F1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验